Collagen VI and cancer
View Patent ↗Methods of determining whether a cancer is progressing by measuring surface-bound collagen VIα3 are provided. Also provided are methods of identifying hyperplasia in a tissue by measuring surface-bound collagen VIα3. Additionally, methods of identifying carcinoma in a tissue by measuring surface-bound collagen VIα3 are provided. Further provided are methods of imaging carcinoma in a tissue by staining the tissue with a specific binding partner to collagen VIα3. Methods of treating a cancer by preventing binding of collagen VIα3 onto cells of the cancer are additionally provided.
1. A method of identifying hyperplasia in a tissue, the method comprising identifying epithelial cells of the tissue that have more surface-bound collagen VIα3 carboxy-terminus than full length collagen VI protein, wherein the epithelial cells of the tissue that have more surface-bound collagen VIα3 carboxy-terminus than full length collagen VI protein exhibit hyperplasia, and wherein the surface-bound collagen VIα3 carboxy-terminus is identified using an antibody that specifically binds to collagen VIα3 carboxy-terminus or an antigen-binding fragment that specifically binds to collagen VIα3 carboxy-terminus.
2. The method of claim 1 , wherein the tissue is breast, ovarian or colon tissue.
3. The method of claim 1 , wherein the tissue is breast tissue.
4. The method of claim 1 , wherein the tissue is from a biopsy.
5. The method of claim 1 , wherein the surface collagen is identified using an antibody that specifically binds to collagen VIα3 carboxy-terminus.
6. The method of claim 1 , wherein the surface collagen VIα3 is identified using an antigen-binding fragment that specifically binds to collagen VIα3 carboxy-terminus.
7. The method of claim 5 , wherein the antibody is labeled with a detectable label.
8. The method of claim 1 , wherein the surface-bound collagen VIα3 is detected using histology and light microscopy.
9. The method of claim 1 , wherein the surface-bound collagen VIα3 is detected using a cell sorter or cell counter.
10. The method of claim 1 , wherein the cells with bound collagen VIα3 is detected using autoradiography or a gamma camera.
11. A method of identifying carcinoma in a tissue, the method comprising identifying epithelial cells that have more surface-bound collagen VIα3 carboxy-terminus than full length collagen VI protein, wherein epithelial cells of the tissue that have more surface-bound collagen VIα3 carboxy-terminus than full length collagen VI protein are carcinoma, and wherein the surface-bound collagen VIα3 carboxy-terminus is identified using an antibody that specifically binds to collagen VIα3 carboxy-terminus or an antigen-binding fragment that specifically binds to collagen VIα3 carboxy-terminus.
12. The method of claim 11 , wherein the carcinoma is breast, ovarian or colon cancer.
13. The method of claim 11 , wherein the carcinoma is breast cancer.
14. The method of claim 11 , wherein the tissue are from a biopsy.
15. The method of claim 11 , wherein the surface collagen is identified using an antibody that specifically binds to collagen VIα3 carboxy-terminus.
16. The method of claim 11 , wherein the surface collagen is identified using an antigen-binding fragment that specifically binds to collagen VIα3 carboxy-terminus.
17. The method of claim 15 , wherein the antibody is labeled with a detectable label.
18. The method of claim 11 , wherein the surface-bound collagen VIα3 is detected using histology and light microscopy.
19. The method of claim 11 , wherein the surface-bound collagen VIα3 is detected using a cell sorter or cell counter.
20. The method of claim 11 , wherein the cells with bound collagen VIα3 is detected using autoradiography or a gamma camera.